跳至主要内容
临床试验/NCT01064063
NCT01064063已完成不适用

Randomized Controlled Clinical Evaluation to Compare Vanguard Cruciate Retaining and AGC Total Condylar Knee Implants

Zimmer Biomet2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2011年2月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Zimmer Biomet
入组人数
150
试验地点
2
主要终点
American Knee Society Knee Score

研究概览

简要总结

This evaluation is being conducted on the relative new knee system, the Vanguard Cruciate Retaining (CR) to evaluate clinical efficacy of the Vanguard CR components.

详细描述

This clinical trial was initially designed as a multi-centre, randomized controlled study, comparing the Vanguard CR with the AGC in routine use. The study now is a single centre study.

The Vanguard CR system has been specifically designed to give greater knee stability through the use of more anatomic patello-femoral kinematics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pre-op knee score of <70
  • Scheduled to undergo primary total knee replacement with any of the following indication:
  • pain and disabled knee joint resulting from Osteoarthritis, Rheumatoid Arthritis, or Traumatic arthritis.
  • One or more compartments involved.
  • Need to obtain pain relief and improve function
  • Ability and willingness to follow instructions, including control of weight and activity level, and to return for follow-up evaluations
  • A good nutritional state of the patient
  • Full skeletal maturity of the patient, patients who are at least 18 years of age.
  • Patients of either sex
  • Consent form read, understood, and signed by patient

排除标准

  • Pre-op knee score greater than or equal to 70
  • Infection
  • Osteomyelitis
  • Previous partial or total prosthetic knee replacement on the operative side
  • Skeletal immaturity of the patient, patients who are less than 18 years of age.
  • Uncooperative patient or patient with neurological disorders who are incapable of following directions
  • Osteomalacia
  • Distant foci of infections
  • Rapid joint destruction, marked bone loss, or bone resorption apparent on roentgenogram
  • Vascular insufficiency, muscular atrophy, or neuromuscular disease in affected limb
  • Incomplete or deficient soft tissue surrounding the knee

结局指标

主要结局

American Knee Society Knee Score

时间窗: 2 year

Objective scoring system to rate the knee and patient's functional abilities before and after TKA

次要结局

  • Survivorship(10 years)
  • American Knee Society Score, Oxford Knee-12, SF-12(6w, 6m, 1y, 2y, 3y, 5y, 7y, 10y)
  • Patient success(2 year)
  • Noble & Weiss Knee Score, Kujala Score(6w, 6m, 1y, 2y)
  • Radiographic evaluation(6m,1y, 2y, 3y, 5y, 10y)
  • Adverse Events(any)

研究者

发起方
Zimmer Biomet
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Randomized Controlled Clinical Evaluation to Compare... | 临床试验